Teva Pharmaceutical Industries (NYSE:TEVA) shareholders are up 5.9% this past week, but still in the red over the last five years - Simply Wall St News
Teva Pharmaceutical Industries Limited's (TEVA) Net Worth at $10.306 Billion
Teva Pharmaceutical: 2023 Could Finally Be The Stock's Breakout Year (NYSE: TEVA) | Seeking Alpha